The Effect of the Antioxidant (GliSODin) on Unexplained Fatigue

Phase 1

Completed

• Conditions: Fatigue; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12607000420448
• Lead Sponsor: Applied Science & Nutrition

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-08-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Unexplained fatigue of greater than 3 months' duration

Exclusion Criteria

Clinical Depression, Diagnosed Thyroid Disorder, Iron-deficiency anaemia, Coeliac Disease, Any serious disease, History of Alcohol or Drug Abuse, Primary Sleep Disorder

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective markers of fatigue[12 weeks]

Secondary Outcome Measures

Name	Time	Method
Blood levels of endogenous antioxidant enzymes, Superoxide dismutase (SOD) and Glutathione peroxidase[Baseline, 6 weeks and 12 weeks];To evaluate the effects of the intervention on several biochemical markers of oxidative stress, before during and after 12 weeks of treatment.[Baseline, 6 weeks and 12 weeks];To evaluate the blood levels of stress-related hormones[Baseline, 6 weeks, 12 weeks]